|
|
|
|
|
My Recent Searches
|
|
|
|
|
|
|
Fortress Biotech, Inc. (FBIO) |
|
|
$0.29 0.00 (0.00%) as of 4:30 Mon 10/9
|
|
Download |
|
|
|
|
Exchange: |
N/A |
Security
Type: |
N/A |
Shares
Out: |
93,700,000 |
Market
Cap: |
26.82(M) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$0.2833 - $0.71 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Fortress Biotech is a biopharmaceutical company focused on acquiring, developing and commercializing pharmaceutical and biotechnology products and product candidates. Through its partner company, Co. markets dermatology products including Qbrexza®, which is a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane® (isotretinoin) capsule, which is an oral retinoid indicated for the treatment of severe recalcitrant nodular acne; as well as Ximino® (minocycline hydrochloride) extended release capsule, which is a tetracycline-class drug indicated to treat only inflammatory lesions of non-nodular moderate to severe acne vulgaris.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
10,000 |
60,000 |
1,894,573 |
6,056,667 |
Total Buy Value |
$17,589 |
$136,359 |
$3,290,364 |
$6,733,423 |
Total People Bought |
1 |
1 |
2 |
6 |
Total Buy Transactions |
1 |
2 |
7 |
17 |
Total Shares Sold |
10,000 |
10,000 |
10,000 |
10,000 |
Total Sell Value |
$18,900 |
$18,900 |
$18,900 |
$18,900 |
Total People Sold |
1 |
1 |
1 |
1 |
Total Sell Transactions |
1 |
1 |
1 |
1 |
End Date |
2024-03-03 |
2023-12-01 |
2023-06-02 |
2022-06-02 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Klein Dov |
Director |
|
2015-07-15 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
55,000 |
|
- |
|
Rosenwald Lindsay A Md |
President and CEO |
|
2015-06-01 |
4 |
B |
$1.80 |
$1,413 |
D/D |
785 |
4,792,106 |
3.15 |
- |
|
Lobell J Jay |
Director |
|
2015-03-12 |
4 |
A |
$0.00 |
$0 |
D/D |
100,000 |
486,000 |
|
- |
|
Rowinsky Eric K |
Director |
|
2015-03-12 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
150,000 |
|
- |
|
Rowinsky Eric K |
Director |
|
2015-03-12 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
100,000 |
|
- |
|
Lu Lucy |
Chief Financial Officer |
|
2014-12-01 |
4 |
B |
$1.45 |
$7,250 |
D/D |
5,000 |
35,631 |
2.74 |
- |
|
Rosenwald Lindsay A Md |
President and CEO |
|
2014-12-01 |
4 |
B |
$1.45 |
$1,412 |
D/D |
974 |
4,791,321 |
3.15 |
- |
|
Lu Lucy |
Chief Financial Officer |
|
2014-06-02 |
4 |
B |
$1.37 |
$6,850 |
D/D |
5,000 |
30,631 |
2.74 |
- |
|
Horgan Kevin |
Former Chief Medical Officer |
|
2014-04-22 |
4 |
S |
$1.89 |
$89,976 |
D/D |
(47,566) |
0 |
|
- |
|
Horgan Kevin |
Former Chief Medical Officer |
|
2014-04-22 |
4 |
OE |
$1.71 |
$81,338 |
D/D |
47,566 |
47,566 |
|
- |
|
Horgan Kevin |
Former Chief Medical Officer |
|
2014-04-21 |
4 |
S |
$1.81 |
$34,382 |
D/D |
(19,000) |
0 |
|
- |
|
Horgan Kevin |
Former Chief Medical Officer |
|
2014-04-21 |
4 |
OE |
$1.71 |
$32,490 |
D/D |
19,000 |
19,000 |
|
- |
|
Horgan Kevin |
Former Chief Medical Officer |
|
2014-04-17 |
4 |
S |
$1.85 |
$187 |
D/D |
(101) |
0 |
|
- |
|
Horgan Kevin |
Former Chief Medical Officer |
|
2014-04-17 |
4 |
OE |
$1.71 |
$173 |
D/D |
101 |
101 |
|
- |
|
Harvey Jimmie |
Director |
|
2014-02-20 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
50,000 |
|
- |
|
Barrett David Jonathan |
Director |
|
2014-02-20 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
50,000 |
|
- |
|
Lobell J Jay |
Director |
|
2014-02-20 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
386,000 |
|
- |
|
Rowinsky Eric K |
Director |
|
2014-02-20 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
50,000 |
|
- |
|
Weiss Michael S |
Exec. VC - Strategic Dev. |
|
2014-02-20 |
4 |
A |
$0.00 |
$0 |
D/D |
3,958,692 |
5,938,038 |
|
- |
|
Hoenlein Malcolm |
Director |
|
2014-02-20 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
30,000 |
|
- |
|
Weiss Michael S |
Director |
|
2013-12-19 |
4 |
A |
$0.00 |
$0 |
D/D |
1,979,346 |
1,979,346 |
|
- |
|
Rosenwald Lindsay A Md |
President and CEO |
|
2013-12-19 |
4 |
A |
$0.00 |
$0 |
D/D |
1,979,346 |
4,638,347 |
|
- |
|
Lu Lucy |
Chief Financial Officer |
|
2013-12-04 |
4 |
B |
$1.39 |
$1,539 |
D/D |
1,107 |
25,631 |
2.66 |
- |
|
Lobell J Jay |
Director |
|
2013-08-21 |
4 |
B |
$7.37 |
$36,850 |
D/D |
5,000 |
336,000 |
2.39 |
- |
|
Lu Lucy |
Chief Financial Officer |
|
2013-08-21 |
4 |
B |
$7.38 |
$36,900 |
D/D |
5,000 |
24,524 |
2.74 |
- |
|
211 Records found
|
|
Page 7 of 9 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|